Robert W. Duggan - 06 Dec 2022 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Executive Officer, Director
Signature
/s/ Robert W. Duggan
Issuer symbol
SMMT
Transactions as of
06 Dec 2022
Net transactions value
$0
Form type
4
Filing time
08 Dec 2022, 17:28:13 UTC
Previous filing
18 Aug 2022
Next filing
08 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Other +9,346,434 +5.8% 171,879,226 06 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 9,346,434 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Dr. Maky Zanganeh. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79.